Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 10 Apr 2025

Pan-cancer analysis identified CD248 as a potential target for multiple tumor types

in Pharmacology of Anti-Cancer Drugs

Li Guo
Yan Liao
Xuyang Zhang
Rongjuan Guo
Zheng Wang
Deqin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554632

166 views

Review

Accepted on 09 Apr 2025

Studies on the Mechanism of Ototoxic Action of Cisplatin and the Antagonistic Effect of Polyphenolic Compounds

in Pharmacology of Anti-Cancer Drugs

Yuhua Chi
Shengyu Han
Jinjun Sun
Wenpeng Li
Jihong Li
Haoming Yu
Shuai Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586243

Editorial

Accepted on 09 Apr 2025

Editorial: Multi-omics Application in Exploring Potential Biomarkers Targeting Resistance of Anti-Cancer Drugs

in Pharmacology of Anti-Cancer Drugs

Huan Wang
Jindong Xie
Zhi Tian
Diane S Allen-Gipson
Hailin Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594064

Editorial

Accepted on 09 Apr 2025

Editorial: Autophagy and Lung Cancer Therapy: Targeted Drug Development and New Emerging Technology

in Pharmacology of Anti-Cancer Drugs

Ming Zhang
Yu Wang
Chunhui Yang
Xin You
Yafei Feng
Xianglin Yang
Qi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599548

Original Research

Accepted on 09 Apr 2025

Synthesis, Anti-cancer Activity, and Mechanistic Insights of 2H-benzo[b][1,4]oxazin-3(4H)-one Linked 1,2,3-Triazoles in Human Cancer Cell Lines

in Pharmacology of Anti-Cancer Drugs

Qing-Ying Liu
Xixi Hou
Mingyue Tian
Baoyu He
Jingjing Guo
Yajie Guo
Jianxue Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565657

Original Research

Published on 09 Apr 2025

The biological function and prognostic significance of ferroptosis-related genes in clear cell renal cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Huizhen Ye
Xiwen Wu
Gehao Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1515552

133 views

Original Research

Accepted on 08 Apr 2025

Integrative Analysis of m6A-SNPs and Single-Cell RNA Sequencing Reveals Key Drivers of Endocrine Combined with CDK4/6 Inhibitor Therapy Resistance in ER+ Breast Cancer

in Pharmacology of Anti-Cancer Drugs

Ruijie Ming
Han Zhang
Han Zhang
Fangbiao Zhan
Xiaoping Huang
Huawen Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590363

Review

Published on 08 Apr 2025

A novel perspective on bone tumors: advances in organoid research

in Pharmacology of Anti-Cancer Drugs

Zebing Ma
Yibing Liu
Rui Chen
Huayu Fan
Liang Kong
Xiangyang Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1550163

156 views

Original Research

Published on 08 Apr 2025

MDM2 inhibitor induces apoptosis in colon cancer cells through activation of the CHOP-DR5 pathway, independent of p53 phenotype

in Pharmacology of Anti-Cancer Drugs

Manman Lu
Yingli Ren
Sijia Feng
Shenggen Wang
Weiyue Xia
Baoru Gu
Yuhou Shen
Aimin Yue
Na Li
Yongxi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1508421

251 views

Original Research

Accepted on 07 Apr 2025

The Mechanistic Study of Codonopsis pilosula on Laryngeal Squamous Cell Carcinoma Based on Network Pharmacology and Experimental Validation

in Pharmacology of Anti-Cancer Drugs

Huina Guo
Yichen Lou
Xiaofang Hou
Guan Xiaoya
Yujia Guo
Han Qi
Xuting Xue
Ying Wang
Long He
Zhongxun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1542116

Review

Accepted on 07 Apr 2025

Parthenolide: Pioneering New Frontiers in Hematological Malignancies

in Pharmacology of Anti-Cancer Drugs

Azadeh Omidkhoda
Elmira Zarei
Ayda Zarei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534686

Mini Review

Accepted on 07 Apr 2025

Research progress of ferroptosis and PARP inhibitor in ovarian cancer ： action mechanism and resistance mechanism

in Pharmacology of Anti-Cancer Drugs

Jiqing Zhang
Mu Liu
Yuting Xiang
Zhongjun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598279

Original Research

Published on 07 Apr 2025

Miltirone enhances the chemosensitivity of gastric cancer cells to cisplatin by suppressing the PI3K/AKT signaling pathway

in Pharmacology of Anti-Cancer Drugs

Yiping Wang
Hang Lv
Li Shen
Zhe Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1553791

243 views

Systematic Review

Published on 07 Apr 2025

A bibliometric and visual analysis based on immune checkpoint inhibitors for hepatocellular carcinoma: 2014 – 2024

in Pharmacology of Anti-Cancer Drugs

Gao-Min Liu
Rui Guo
Ji-Wei Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1520055

115 views

Original Research

Accepted on 04 Apr 2025

Adverse reactions of four multi-targeted tyrosine kinase inhibitors: a descriptive analysis of the WHO-VigiAccess database

in Pharmacology of Anti-Cancer Drugs

Lijun Li
Jiayu Bai
Xuelong Wen
Xuefan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585862

Original Research

Accepted on 04 Apr 2025

Multiscale Screening and Identifying Specific Targets for Artesunate in Suppressing Bladder Cancer

in Pharmacology of Anti-Cancer Drugs

Yi Yuan
Guangdi Chu
Qingyue Ma
Zhijuan Liang
Ye Liang
Haitao Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584502